[1]
S. Tanida, “Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Upadacitinib for Induction Treatment of Refractory Crohn’s Disease”, J Clin Med Res, vol. 17, no. 4, pp. 240–246, Apr. 2025, doi: 10.14740/jocmr6188.